Corteva (NYSE:CTVA) Price Target Raised to $100.00

Corteva (NYSE:CTVA) had its price target lifted by BMO Capital Markets from $95.00 to $100.00 in a research note published on Monday morning, Marketbeat Ratings reports. The firm currently has an outperform rating on the stock.

A number of other research firms have also recently weighed in on CTVA. Morgan Stanley raised their price target on Corteva from $84.00 to $95.00 and gave the company an “overweight” rating in a report on Thursday, May 28th. Rothschild & Co Redburn increased their price objective on shares of Corteva from $80.00 to $90.00 and gave the stock a “neutral” rating in a research note on Wednesday, April 29th. CICC Research boosted their price target on Corteva from $80.00 to $93.00 and gave the stock an “outperform” rating in a research report on Wednesday, May 13th. UBS Group decreased their price objective on Corteva from $90.00 to $86.00 and set a “neutral” rating on the stock in a report on Tuesday, June 9th. Finally, BNP Paribas Exane lifted their price objective on Corteva from $74.00 to $77.00 in a report on Wednesday, May 6th. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and eight have given a Hold rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $91.38.

Corteva Trading Up 0.7%

Shares of NYSE CTVA opened at $78.82 on Monday. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.07. Corteva has a one year low of $60.53 and a one year high of $90.97. The business has a 50-day moving average price of $82.03 and a two-hundred day moving average price of $79.79. The firm has a market capitalization of $52.59 billion, a PE ratio of 52.20, a PEG ratio of 2.39 and a beta of 0.57.

Corteva (NYSE:CTVA) last posted its earnings results on Thursday, July 30th. The company reported $2.30 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.24 by $0.06. Corteva had a net margin of 5.66% and a return on equity of 10.18%. The firm had revenue of $6.38 billion during the quarter, compared to analysts’ expectations of $6.60 billion. During the same period in the previous year, the company earned $2.20 earnings per share. The company’s revenue was down 1.2% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. As a group, analysts predict that Corteva will post 3.74 earnings per share for the current fiscal year.

Corteva Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 15th. Shareholders of record on Tuesday, September 1st will be issued a $0.18 dividend. The ex-dividend date is Tuesday, September 1st. This represents a $0.72 annualized dividend and a yield of 0.9%. Corteva’s dividend payout ratio is presently 47.68%.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the business. JPL Wealth Management LLC purchased a new position in shares of Corteva during the third quarter valued at approximately $25,000. Garton & Associates Financial Advisors LLC purchased a new stake in Corteva during the fourth quarter worth about $27,000. Bank of Jackson Hole Trust bought a new stake in shares of Corteva in the 4th quarter worth approximately $28,000. Cornerstone Financial Management LLC bought a new stake in shares of Corteva in the fourth quarter valued at $29,000. Finally, Elevation Wealth Partners LLC boosted its position in Corteva by 334.6% during the second quarter. Elevation Wealth Partners LLC now owns 339 shares of the company’s stock worth $29,000 after purchasing an additional 261 shares during the period. 81.54% of the stock is currently owned by institutional investors and hedge funds.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid?2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.